Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
60.0%
% of BBH's 27 holdings also in XBI
11.0%
% of XBI's 136 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.0% | 3.5% | 3.5% |
|
GILEAD SCIENCES INC | 10.9% | 3.0% | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 10.8% | 2.6% | 2.6% |
|
ALNYLAM PHARMACEUTICALS INC | 3.3% | 2.5% | 2.5% |
|
NEUROCRINE BIOSCIENCES INC | 2.4% | 2.8% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to XBI
|
AMGEN INC | 13.1% |
|
VERTEX PHARMACEUTICALS INC | 8.2% |
|
GILEAD SCIENCES INC | 7.9% |
 |
ARGENX SE ADR | 5.6% |
|
REGENERON PHARMACEUTICALS | 4.8% |
|
IQVIA HOLDINGS INC | 4.6% |
|
ILLUMINA INC | 4.4% |
 |
ICON PLC | 3.5% |
 |
BIONTECH SE SPONSORED ADR | 2.7% |
|
BIO-TECHNE CORPORATION | 2.2% |
BBH Underweight Relative to XBI
|
UNITED THERAPEUTICS CORP | -2.9% |
|
ADVENTRX PHARMACEUTICALS INC | -2.8% |
|
ABBVIE INC | -2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.2% |
|
VIKING THERAPEUTICS, INC. | -1.9% |
|
BLUEPRINT MEDICINES CORP. | -1.7% |
|
TG THERAPEUTICS INC | -1.7% |
|
CRISPR THERAPEUTICS AG | -1.5% |
|
HALOZYME THERAPEUTICS INC | -1.4% |
|
INCYTE CORP | -1.3% |